← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2017Last known activity
Feb 28, 2019
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (2)
- NCT03823781Study directorPhase 3Feb 28, 2019
- NCT03321123Overall official - principal investigatorPhase 2Dec 1, 2017
Details
- Last known activity
- Feb 28, 2019